2023年吉尔吉斯斯坦季节性流感疫苗接种规划实施后评估(PIE)
吉尔吉斯斯坦于2023年开展流感疫苗接种规划实施后评估,在该国六个地区进行现场访视,使用标准化问卷访谈国家、地区、区级工作人员、卫生机构人员及流感疫苗优先接种人群。评估发现两大挑战:流感疫苗供应不足以覆盖优先人群,以及孕妇对流感疫苗的接受度和接种率低。
要点
- 评估覆盖吉尔吉斯斯坦六个地区,访谈国家、地区、区级及卫生机构人员和优先人群。
- 发现流感疫苗供应不足以覆盖优先人群是主要挑战之一。
- 发现孕妇对流感疫苗的接受度和接种率低是另一主要挑战。
核心结论
- 评估识别出流感疫苗供应不足以覆盖优先人群以及孕妇对流感疫苗接受度和接种率低两大挑战,这些发现可为制定针对性策略和政策更新提供依据,以提高吉尔吉斯斯坦流感疫苗实施和接种率。
研究设计与样本
- 2023年在吉尔吉斯斯坦开展流感疫苗接种规划实施后评估,在该国六个地区进行现场访视,使用标准化问卷访谈国家、地区、区级工作人员、卫生机构人员及流感疫苗优先接种人群。
主要发现
- 评估发现两大主要挑战:流感疫苗供应不足以覆盖优先人群,以及孕妇对流感疫苗的接受度和接种率低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination is an effective preventive strategy against influenza. Kyrgyzstan introduced a comprehensive influenza vaccination program in 2013 and has collaborated with the Task Force for Global Health since 2017 to expand vaccination coverage. In 2023, an influenza vaccine post-introduction evaluation was conducted to identify strengths and weaknesses in the influenza vaccination program and to identify measures for improvement. Site visits were conducted across six regions of the country and interviews were conducted with national, regional and district staff, health facility staff, and individuals from priority populations for influenza vaccination using standardized questionnaires. Two major challenges identified in this evaluation were the inadequate supply of influenza vaccine to cover the priority groups and the low acceptance and uptake of influenza vaccine among pregnant people. These findings are important as they can inform targeted strategies and policy updates to increase influenza vaccine implementation and uptake in Kyrgyzstan.
引用
- Otorbaeva D, Akmatova R, Cooley KM, et al. Post-introduction evaluation (PIE) of the seasonal influenza vaccination program in Kyrgyzstan in 2023. Vaccine. 2025. PMID: 40174255. doi:10.1016/j.vaccine.2025.127052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。